These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1831230)

  • 1. The difference in clearance between kit-prepared technetium-99m-MAG3 and radioiodinated hippuric acid.
    Bubeck B; Brandau W
    J Nucl Med; 1991 Aug; 32(8):1642-4. PubMed ID: 1831230
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of renal function using MAG3.
    Russell CD; Dubovsky EV
    J Nucl Med; 1991 Nov; 32(11):2061-3. PubMed ID: 1834813
    [No Abstract]   [Full Text] [Related]  

  • 3. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
    Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
    J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique.
    Russell CD; Thorstad B; Yester MV; Stutzman M; Baker T; Dubovsky EV
    J Nucl Med; 1988 Jul; 29(7):1189-93. PubMed ID: 2969040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of renal function with technetium-99m MAG3.
    Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
    J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the clearance of technetium-99m MAG3 and iodine-131 OIH.
    Kim CK; Stritzke P; Goldsmith SJ
    J Nucl Med; 1988 Nov; 29(11):1878-9. PubMed ID: 2972816
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.
    Eshima D; Taylor A; Fritzberg AR; Kasina S; Hansen L; Sorenson JF
    J Nucl Med; 1987 Jul; 28(7):1180-6. PubMed ID: 2955085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparison of two algorithms for determining renal whole body clearance following simultaneous acquisition with a partially shielded whole-body counter and a gamma camera].
    Kotzerke J; Wallburger M; Gettner U; Burchert W; Hundeshagen H
    Nuklearmedizin; 1990 Jun; 29(3):101-8. PubMed ID: 2144044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations under consideration of body dimensions: a general requirement for single-sample clearance determinations.
    Bubeck B
    J Nucl Med; 1992 Apr; 33(4):629-30. PubMed ID: 1532420
    [No Abstract]   [Full Text] [Related]  

  • 12. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
    Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
    Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimate of relative function and transit time in renographic studies.
    González A; Ros D; Pavia J
    J Nucl Biol Med (1991); 1994 Sep; 38(3):502-7. PubMed ID: 7865547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of technetium-99m-MAG3 renal clearance in children: two gamma camera techniques compared with multiple plasma samples.
    Gordon I; Anderson PJ; Orton M; Evans K
    J Nucl Med; 1991 Sep; 32(9):1704-8. PubMed ID: 1831838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of single-injection multisample renal clearance methods with and without urine collection.
    Russell CD; Dubovsky EV
    J Nucl Med; 1995 Apr; 36(4):603-6. PubMed ID: 7699449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radionuclide renal imaging in the United States.
    Gates GF
    Eur J Nucl Med; 1995 Sep; 22(9):1081-4. PubMed ID: 7588949
    [No Abstract]   [Full Text] [Related]  

  • 19. Towards standardization in gamma camera renography.
    Cosgriff PS; Lawson RS; Nimmon CC
    Nucl Med Commun; 1992 Aug; 13(8):580-5. PubMed ID: 1387465
    [No Abstract]   [Full Text] [Related]  

  • 20. Using the "integral spleen" method of radiorenogram analysis and a baboon model to compare the diagnostic usefulness of technetium-99m-diethylenetriamine pentaacetic acid to that of various technetium-99m-mercaptoacetyltriglycene formulations and iodine-123-hippuran.
    Dormehl IC; Van Wyk A; Pilloy W; Maree M; Knoesen O; De Winter R; Jacobs L; Hoppe HC
    Am J Physiol Imaging; 1989; 4(1):23-7. PubMed ID: 2522307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.